These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


318 related items for PubMed ID: 26743078

  • 1. Treatment of IgA nephropathy with renal insufficiency.
    Pozzi C, Sarcina C, Ferrario F.
    J Nephrol; 2016 Aug; 29(4):551-8. PubMed ID: 26743078
    [Abstract] [Full Text] [Related]

  • 2. Treatment of IgA nephropathy.
    Pozzi C.
    J Nephrol; 2016 Feb; 29(1):21-5. PubMed ID: 26577268
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of IgA nephropathy with chronic renal failure].
    Pozzi C.
    G Ital Nefrol; 2008 Feb; 25 Suppl 44():83-7. PubMed ID: 19048591
    [Abstract] [Full Text] [Related]

  • 4. Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.
    Tesar V, Troyanov S, Bellur S, Verhave JC, Cook HT, Feehally J, Roberts IS, Cattran D, Coppo R, VALIGA study of the ERA-EDTA Immunonephrology Working Group.
    J Am Soc Nephrol; 2015 Sep; 26(9):2248-58. PubMed ID: 25677392
    [Abstract] [Full Text] [Related]

  • 5. Pro: STOP immunosuppression in IgA nephropathy?
    Pozzi C.
    Nephrol Dial Transplant; 2016 Nov; 31(11):1766-1770. PubMed ID: 27515694
    [Abstract] [Full Text] [Related]

  • 6. Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.
    Moriyama T, Nakayama K, Ochi A, Amemiya N, Tsuruta Y, Kojima C, Itabashi M, Takei T, Uchida K, Nitta K.
    Clin Exp Nephrol; 2012 Apr; 16(2):231-7. PubMed ID: 22038185
    [Abstract] [Full Text] [Related]

  • 7. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effects of cytotoxic therapy in progressive IgA nephropathy.
    Shin JH, Lee JE, Park JH, Lim S, Jang HR, Kwon GY, Huh W, Jung SH, Kim YG, Oh HY, Kim DJ.
    Ann Med; 2016 Dec; 48(3):171-81. PubMed ID: 27031662
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Management of IgA nephropathy].
    Amoroso L, De Sanctis L, Cappelli P, Di Vito R, Sirolli V, Bonomini M.
    G Ital Nefrol; 2011 Dec; 28(6):622-32. PubMed ID: 22167613
    [Abstract] [Full Text] [Related]

  • 13. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X, Liu Y, Lv J, Shi S, Liu L, Chen Y, Zhang H.
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):484-9. PubMed ID: 24408121
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Mar; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment for IgA nephropathy with stage 3 or 4 chronic kidney disease: low-dose corticosteroids combined with oral cyclophosphamide.
    Ma F, Yang X, Zhou M, Bai M, Zhao L, Li L, Dong R, Liu C, Li R, Sun S.
    J Nephrol; 2020 Dec; 33(6):1241-1250. PubMed ID: 32447619
    [Abstract] [Full Text] [Related]

  • 20. Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy.
    Yoon CY, Chang TI, Kang EW, Lim BJ, Kie JH, Kee YK, Kim H, Park S, Yun HR, Jung SY, Jhee JH, Kwon YE, Oh HJ, Park JT, Yoo TH, Kang SW, Jeong HJ, Han SH.
    Ann Med; 2017 May; 49(3):217-229. PubMed ID: 27764976
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.